| Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637) |
|---|
| 06/07/2012 | WO2012029077A3 Process for preparing fluticasone propionate/furoate |
| 05/30/2012 | CN102482317A 17-羟基-17-五氟乙基-雌-4,9(10)-二烯-11-芳基衍生物、其制备方法及其用于治疗疾病的用途 17- hydroxy-17-pentafluoroethyl - Estrogen-4,9 (10) - dien-11 aryl derivatives, their preparation and their use for the treatment of diseases |
| 05/30/2012 | CN102477060A 新的甾体化合物及其制备方法和用途 New steroid compounds and their preparation and use |
| 05/24/2012 | US20120126107 Enhanced Sensitivity for Analysis of Carbonyl Containing Compounds Using Mass Spectrometry |
| 05/23/2012 | CN102464695A 甘氨胆酸的新晶型及其制备方法 The new crystal form and its preparation method of glycocholate |
| 05/22/2012 | CA2614667C 20-keto-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/17/2012 | US20120122827 Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method |
| 05/16/2012 | EP1888615B1 17 -hsd1 and sts inhibitors |
| 05/15/2012 | CA2517893C Use as medications of cholest-4-en-3-one derivatives, pharmaceutical compounds containing them, new derivatives and their preparation process |
| 05/09/2012 | CN102448978A Novel Glucocorticoid Receptor Agonists |
| 05/02/2012 | CN102439026A Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin |
| 04/12/2012 | WO2012047495A2 Methods for preparing synthetic bile acids and compositions comprising the same |
| 04/12/2012 | DE102010047714A1 Derivate von Steroidbenzylaminen mit antiparasitärer, antibakterieller, antimykotischer und/oder antiviraler Wirkung Derivatives of Steroidbenzylaminen with antiparasitic, antibacterial, antifungal and / or antiviral action |
| 04/05/2012 | US20120083440 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 04/04/2012 | EP2435463A2 Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them |
| 04/04/2012 | EP2435462A1 Novel glucocorticoid receptor agonists |
| 04/03/2012 | CA2491801C Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology |
| 03/29/2012 | US20120077791 Novel crystalline form of antiprogestin cdb-4124 |
| 03/28/2012 | EP2432798A2 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases |
| 03/22/2012 | WO2012035553A1 Process for preparing androstenone derivatives |
| 03/14/2012 | EP2427473A1 Method for the synthesis of glycocholic acid |
| 03/14/2012 | EP2427472A1 Lipophilic polynucleotide conjugates |
| 03/14/2012 | CN102372760A Synthesis method of progesterone receptor regulating agent ulipristal |
| 03/08/2012 | WO2012027957A1 Bufalin derivatives, pharmaceutical compositions and use thereof |
| 03/01/2012 | US20120053162 Certain chemical entities, compositions, and methods |
| 02/29/2012 | EP2421882A2 Angiogenesis inhibitors |
| 02/28/2012 | US8124129 Crystalline form of the compound A-348441 |
| 02/23/2012 | WO2011132045A3 Process for the preparation of dienogest substantially free of impurities |
| 02/22/2012 | EP1163029B1 Nitrate esters and their use for inducing neuroprotection and cognition enhancement |
| 02/21/2012 | CA2248800C Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 02/16/2012 | US20120041182 Water Soluble Cholesterol Derivatives |
| 02/15/2012 | EP2417149A1 Methods for the preparation of drospirenone |
| 02/15/2012 | EP2417148A1 Progesterone antagonists spiro condensed in position 17 with a difluoromethylene- substituted perhydrofurane group |
| 02/09/2012 | US20120035116 Bile acids and biguanides as protease inhibitors for preserving the integrity of peptides in the gut |
| 02/08/2012 | CN102344480A Method for synthesizing dendritic aminosterol substance |
| 02/08/2012 | CN102344478A Crystal of 17 alpha-acetoxyl group-11 beta-(4-N, N-dimethylamino phenyl)-19-norpregna-4, 9- diene-3, 20- ketonic and preparation method thereof |
| 02/07/2012 | US8110564 Bile acid or bile salt fatty acid conjugates |
| 02/07/2012 | CA2488535C Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 02/02/2012 | US20120029167 Auto magnetic metal salen complex compound |
| 01/26/2012 | US20120022035 Polymorphic and Amorphous Salt Forms of Squalamine Dilactate |
| 01/25/2012 | EP2408799A1 Novel crystalline form of antiprogestin cdb-4124 |
| 01/24/2012 | CA2571409C Neoglycorandomization and digitoxin analogs |
| 01/24/2012 | CA2163748C Methods and compositions for inducing sleep |
| 01/18/2012 | EP2407448A2 Processes and intermediates for preparing steric compounds |
| 01/18/2012 | CN102325784A TGR5 modulators and method of use thereof |
| 01/18/2012 | CN102321141A Amorphous substance of 17alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregn-4,9-diene-3,20-diketone and preparation method thereof |
| 01/18/2012 | CN102321140A Lipoid cation function molecule synthesized from natural cholesterol and amino acid and preparation method and application thereof |
| 01/11/2012 | EP2404608A1 Combination use of cholestanol derivative |
| 01/11/2012 | CN102317304A Process for the preparation of cholyl-L-lysine |
| 01/10/2012 | CA2492079C Microbiological processes for the production of 7 alpha-substituted 11 alpha-hydroxy steroids |
| 01/04/2012 | EP1395544B1 Methods of making 21- 4'-(nitrooxyalkyl) benzoate corticosteroid derivatives and intermediates useful in the synthesis thereof |
| 01/03/2012 | US8088758 17β-hydroxysteroid dehydrogenase type I inhibitors |
| 12/29/2011 | US20110319350 Glycoside compounds and pharmaceutical compositions thereof |
| 12/22/2011 | US20110311583 Novel lipids and compositions for the delivery of therapeutics |
| 12/21/2011 | EP2396341A1 Process for the preparation of cholyl-l-lysine |
| 12/21/2011 | CN102286053A 孕甾烯醇酮吡咯化合物及其制备方法 Pregnenolone azole compound and its preparation method |
| 12/14/2011 | CN101798332B 胆酸类偶合物、其制备方法和用途 Conjugate acid class, their preparation and use |
| 12/06/2011 | US8071575 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 11/30/2011 | EP2390260A2 Ester derivative of ethinyl estradiol |
| 11/24/2011 | US20110287436 Detection Of Analytes And Nucleic Acids |
| 11/23/2011 | CN102250185A Glucocorticoid with NMDA ester positioned on site 21 |
| 11/23/2011 | CN101130567B Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 11/16/2011 | CN102241722A Method for purifying ulipristal serving as synthetic progesterone receptor regulator |
| 11/10/2011 | US20110275604 Aminoalkylsterol compounds with antitumoral and neuroprotective activity |
| 11/03/2011 | US20110270151 Image-guided energy deposition for targeted drug delivery |
| 11/02/2011 | CN101466723B Industrial process for the synthesis of 17a-acetoxy-11ss-[4-(n,n-dimethyl-amino)- phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process |
| 10/27/2011 | WO2011132045A2 Process for the preparation of dienogest substantially free of impurities |
| 10/27/2011 | WO2011098437A3 Progesterone receptor antagonists |
| 10/27/2011 | US20110263553 Steroid analogues for neuroprotection |
| 10/20/2011 | WO2011098436A3 Progesterone receptor antagonists |
| 10/19/2011 | EP2376519A1 Tgr5 modulators and method of use thereof |
| 10/19/2011 | CN102219822A Ganoderic acid T amide derivative TLTO-A and synthetic method and application thereof |
| 10/13/2011 | US20110251378 One-pot synthesis of alpha/beta-o-glycolipids |
| 10/12/2011 | EP2160398B1 INDUSTRIAL METHOD FOR THE SYNTHESIS OF 17-ACETOXY-11ß-[4-(DIMETHYLAMINO)-PHENYL]-21-METHOXY-19-NORPREGNA-4,9-DIEN-3,20-DIONE AND THE KEY INTERMEDIATES OF THE PROCESS |
| 10/11/2011 | CA2481561C Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
| 10/05/2011 | CN102206161A Diamine, polymer obtained from reaction with the presence of the diamine, liquid crystal aligning agent containing the polymer, liquid crystal alignment layer and liquid crystal display device |
| 10/04/2011 | US8030296 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 09/29/2011 | WO2011119194A1 Compositions and methods for non-toxic delivery of antiprogestins |
| 09/29/2011 | US20110237504 Delivery agents for enhancing mucosal absorption of therapeutic agents |
| 09/29/2011 | US20110236602 Photoactive materials |
| 09/29/2011 | CA2793712A1 Compositions and methods for non-toxic delivery of antiprogestins |
| 09/15/2011 | US20110224180 Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method |
| 09/14/2011 | EP2364085A1 Releasable cationic lipids for nucleic acids delivery systems |
| 09/14/2011 | CN102186874A New NO releasing steroids derivatives |
| 09/07/2011 | CN101260136B Oestrogen derivatives as inhibitors of steroid sulphatase |
| 09/01/2011 | US20110212935 Compositions and treatment methods-4 |
| 09/01/2011 | US20110212909 Use of Ginsenoside Compound K in the Preparation of a Medicament for the Prevention and Treatment of Atherosclerosis |
| 08/23/2011 | US8003783 Steroid 17 beta -hydroxysteroid dehydrogenase inhibitors substituted with one or more oxime groups, especially aromatase inhibitors used in the treatment of endocrine-dependent tumors, especially breast cancer |
| 08/23/2011 | US8003629 21-substituted progesterone derivatives as new antiprogestational agents |
| 08/18/2011 | CA2789240A1 Progesterone receptor antagonists |
| 08/18/2011 | CA2789237A1 Progesterone receptor antagonists |
| 08/17/2011 | CN101218245B 3-ester prodrugs of ethynylestradiol |
| 08/11/2011 | DE102010007722A1 Progesteronrezeptorantagonisten Progesterone receptor antagonists |
| 08/09/2011 | US7994273 Photoactive materials |
| 08/03/2011 | EP2350296A1 Branched cationic lipids for nucleic acids delivery system |
| 08/03/2011 | EP2121724B1 Novel method for the diastereoselective production of a chiral primary amine on a steroid |
| 07/28/2011 | US20110182828 C20-c21 substituted glucocorticoid receptor agonists |
| 07/27/2011 | EP2348033A2 Process for obtaining 17alfa-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione |
| 07/27/2011 | EP2348031A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 07/27/2011 | EP2348030A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |